VCYT Veracyte Inc.

$5.76 +1.05%

76,543 Shares Traded
120,916 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $44.25 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:15.33%
If Intiated One Month Ago, Shorts Have Realized a Return of:12.46%
If Initiated Five Days ago, Shorts Have Realized a Return of:-1.43%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 2.17%
Short Interest737.54 thousand
Float33.98 million
Short Ratio6.66
Market Cap$193.69 million
Market Maker ActivityDaily Short Volume

News

02-12-2018
Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2017 Financial Results on Tuesday, February 27, 2018 (Business Wire)
01-31-2018
Veracyte to Present at LEERINK Partners 7th Annual Global Healthcare Conference (Business Wire)
01-25-2018
Veracyte Announces 100,000th Afirma Test Performed to Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis (Business Wire)
01-19-2018
Veracyte's Chief Science and Medical Officer to Present at The Precision Medicine World Conference (Business Wire)
01-18-2018
Veracyte Announces Publication of Results from Patient Survey Quantifying the Challenges in Diagnosing Interstitial Lung Disease (Business Wire)
01-08-2018
Veracyte Announces Strategic Realignment and New Appointments to Advance Commercial Growth (Business Wire)
11-28-2017
Veracyte Announces Publication of Data Confirming Analytical Validity of Envisia Genomic Classifier for Use in IPF Diagnosis (Business Wire)
11-21-2017
Biotech Forum Daily Digest: What Now For Sarepta? (SeekingAlpha)
11-15-2017
Veracyte to Present at the Piper Jaffray 29th Annual Healthcare Conference (Business Wire)
11-09-2017
Veracyte Announces New Clinical Utility Data Suggesting Envisia Genomic Classifier Enables as Confident a Diagnosis in IPF as Surgical Pathology (Business Wire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 76.3%

Earnings Stats

PE Ratio -7.02
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $7.57
50 Day Moving Average $6.35
52 Week High $9.8
52 Week Low $5.23



Data provided for free by IEX. Questions? Read the FAQ